secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001213900-22-080602
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed shareholders elect all director nominees and appoint Marcum LLP as auditor at 2022 AGM
--------------------------------------------------------------------------------

- All five director nominees elected: Eric A. Adams (94.90%), Andrew Hull (94.34%), Janet Grove (96.70%), Bryan Baldasare (95.82%), Nicole Lemerond (96.66%).
- Marcum LLP appointed as independent registered public accounting firm with 97.68% votes in favor.
- All proposals approved by shareholders at December 15, 2022 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390022080602/0001213900-22-080602-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390022080602/ea170383-8k_inmedpharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-080602

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer